Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019000015) CELL-FREE MICRORNA SIGNATURES OF PANCREATIC ISLET BETA CELL DEATH
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/000015 International Application No.: PCT/AU2018/000106
Publication Date: 03.01.2019 International Filing Date: 22.06.2018
IPC:
C12Q 1/68 (2018.01) ,G01N 33/48 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
Applicants:
THE UNIVERSITY OF SYDNEY [AU/AU]; Parramatta Road Sydney, NSW 2006, AU
Inventors:
HARDIKAR, Anandwardhan, Awadhoot; AU
JOGLEKAR, Mugdha, Vinay; AU
JANUSZEWSKI, Andrzej, Szczesny; AU
Agent:
SPRUSON & FERGUSON; GPO Box 3898 Sydney, New South Wales 2001, AU
Priority Data:
201790252129.06.2017AU
Title (EN) CELL-FREE MICRORNA SIGNATURES OF PANCREATIC ISLET BETA CELL DEATH
(FR) SIGNATURES DE MICRO-ARN SANS CELLULES DE MORT DE CELLULES BÊTA D'ÎLOTS DE LANGERHANS
Abstract:
(EN) The present invention relates generally to microRNA signatures associated with aberrant insulin production. The microRNA signatures are relevant, for example, to predicting, diagnosing and/or prognosing diseases and conditions associated with aberrant insulin production.
(FR) La présente invention concerne de manière générale des signatures de micro-ARN associées à une production aberrante d'insuline. Les signatures de micro-ARN sont pertinentes, par exemple pour prédire, diagnostiquer et/ou pronostiquer des maladies et des états associés à une production aberrante d'insuline.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)